Indivior Pharmaceuticals Inc. (INDV) vs Liquidia Corporation (LQDA)
- Indivior Pharmaceuticals Inc. INDV 32.45 −3.48%
- Liquidia Corporation LQDA 34.35 −1.24%
Indivior Pharmaceuticals Inc. and Liquidia Corporation are both Drug Manufacturers Specialty & Generic companies. Indivior Pharmaceuticals Inc. is the larger, with a market value of $4.0B against $3.1B — 1.3× the size. Indivior Pharmaceuticals Inc. trades at the lower P/E: 11.2× against 21.9×. Liquidia Corporation grew revenue faster over the last twelve months: 2,233.7% against 13.5%. Liquidia Corporation has the higher net margin (30.7% vs 26.8%) and the lower return on invested capital (121.1% vs 460.5%). Across the 19 metrics below, Liquidia Corporation leads on 11 and Indivior Pharmaceuticals Inc. on 8.
Valuation
Profitability
| Metric | INDV | LQDA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 81.97% | 92.54% | 53.94% |
| Operating margin | 31.56% | 37.39% | 0.00% |
| Net margin | 26.75% | 30.74% | 0.00% |
| Free cash flow margin | (8.34%) | 33.42% | 0.00% |
| Return on equity | (153.12%) | 131.82% | (0.40%) |
| Return on assets | 26.52% | 35.57% | (3.32%) |
| Return on invested capital | 460.53% | 121.05% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack